Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by forhandlarenon Oct 01, 2022 2:55am
348 Views
Post# 34999062

Fundamental issue

Fundamental issueI've interacted with many doctors on a social basis over the year. One thing they usually have in common is that they think they outsmart everyone else on any subject... Especially male doctors! I don't think Howard is an exception and the result is a business disaster.

This leads me to doubt the role of Linda Pullan. Based on the outcome of the abbvie deal combined with comment in previous NR that she has assisted in negotiations I'm led to believe that she has merely been an advisor and Howard has been operational in lead of the activity.

Howard is obviously communicating a dream and lack discernment, because he cannot provide substance to make the dream come true - since he suffer of doctors syndrome as explained above.

I was led to believe that a new CEO is in the works as communicated by PRC Partners that the company had choose as the means to get the message out. But I don't get these vibes from the last update.

This guy is the biggest threat to the company, the CFO is not far behind though, how can one get rid of him? There must be a few actors that have participated in the private placements over the years that cannot be very happy now. I know for sure the Howard has stopped communicate with at least one of them.
<< Previous
Bullboard Posts
Next >>